PURPOSE: To describe ocular abnormalities in patients with Friedreich ataxia (FRDA). METHODS: Patients diagnosed with FRDA by genetic analysis were invited to participate in a prospective cohort. The patients included underwent an extensive ophthalmologic examination, including low-contrast Sloan letter charts test and retinal nerve fiber layer (RNFL) thickness analysis by optical coherence tomography (OCT). RESULTS: Twenty-three patients agreed to participate. In all, 19 patients (83%) had a visual acuity of at least 0.8 in both eyes. Fundus examination showed diffuse optic nerve pallor in four patients. However, OCT showed a decreased mean peripapillary RNFL thickness in all but three adult cases and one teenager. The RNFL thickness was found to have a positive correlation with visual acuity (P=0.001) and contrast sensitivity (P=0.001) and a negative correlation with time elapsed from diagnosis (P=0.001). CONCLUSIONS: OCT and low contrast test sensitivity show that the visual pathway is affected in FRDA. However, in most patients there is no significant visual impairment. In a small proportion of patients visual acuity declines with disease progression. This study provides a better understanding of the ophthalmic features of FRDA.
PURPOSE: To describe ocular abnormalities in patients with Friedreich ataxia (FRDA). METHODS:Patients diagnosed with FRDA by genetic analysis were invited to participate in a prospective cohort. The patients included underwent an extensive ophthalmologic examination, including low-contrast Sloan letter charts test and retinal nerve fiber layer (RNFL) thickness analysis by optical coherence tomography (OCT). RESULTS: Twenty-three patients agreed to participate. In all, 19 patients (83%) had a visual acuity of at least 0.8 in both eyes. Fundus examination showed diffuse optic nerve pallor in four patients. However, OCT showed a decreased mean peripapillary RNFL thickness in all but three adult cases and one teenager. The RNFL thickness was found to have a positive correlation with visual acuity (P=0.001) and contrast sensitivity (P=0.001) and a negative correlation with time elapsed from diagnosis (P=0.001). CONCLUSIONS: OCT and low contrast test sensitivity show that the visual pathway is affected in FRDA. However, in most patients there is no significant visual impairment. In a small proportion of patientsvisual acuity declines with disease progression. This study provides a better understanding of the ophthalmic features of FRDA.
Authors: Darren R Hocking; Joanne Fielding; Louise A Corben; Phillip D Cremer; Lynette Millist; Owen B White; Martin B Delatycki Journal: Cerebellum Date: 2010-09 Impact factor: 3.847
Authors: Lisa S Friedman; Jennifer M Farmer; Susan Perlman; George Wilmot; Christopher M Gomez; Khalaf O Bushara; Katherine D Mathews; S H Subramony; Tetsuo Ashizawa; Laura J Balcer; Robert B Wilson; David R Lynch Journal: Mov Disord Date: 2010-03-15 Impact factor: 10.338
Authors: Leonardo Emberti Gialloreti; Matteo Pardini; Francesca Benassi; Sara Marciano; Mario Amore; Maria Giulia Mutolo; Maria Cristina Porfirio; Paolo Curatolo Journal: J Autism Dev Disord Date: 2014-04
Authors: Majda Hadziahmetovic; Usha Kumar; Ying Song; Steven Grieco; Delu Song; Yafeng Li; John W Tobias; Joshua L Dunaief Journal: Invest Ophthalmol Vis Sci Date: 2012-08-07 Impact factor: 4.799
Authors: Duncan E Crombie; Nicole Van Bergen; Kathryn C Davidson; Sara Anjomani Virmouni; Penny A Mckelvie; Vicki Chrysostomou; Alison Conquest; Louise A Corben; Mark A Pook; Tejal Kulkarni; Ian A Trounce; Martin F Pera; Martin B Delatycki; Alice Pébay Journal: Biochem Biophys Rep Date: 2015-09-11
Authors: Pilar Rojas; Ana I Ramírez; Rosa de Hoz; Manuel Cadena; Antonio Ferreras; Blanca Monsalve; Elena Salobrar-García; José L Muñoz-Blanco; José L Urcelay-Segura; Juan J Salazar; José M Ramírez Journal: Diagnostics (Basel) Date: 2020-01-29